Business Description
Kuangli Bio-Tech Holdings Co Ltd
ISIN : KYG532651075
Description
Kuangli Bio-Tech Holdings Co Ltd is engaged in the manufacture and trading of various types of panels, including mobile phone panels, digital camera windows, PDA panels, and instrument panels. The Company is also engaged in the development, manufacturing, and trading of cosmetics, skin care products, and other related biotechnology products. It generates revenue from the manufacture and sale of cosmetics and skincare products, and the sale of health supplements, with sales of cosmetic products being its primary source of revenue. Its operating segments are the Biotechnology Segment and the Health Management Segment, with the Biotechnology Segment generating the majority of revenue. The Company operates in China and Taiwan, with China contributing the majority of revenue.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.64 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.84 | |||||
Debt-to-EBITDA | -5.27 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.91 | |||||
Beneish M-Score | -3.08 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12.6 | |||||
3-Year EBITDA Growth Rate | -80.9 | |||||
3-Year EPS without NRI Growth Rate | -17.5 | |||||
3-Year FCF Growth Rate | -29.2 | |||||
3-Year Book Growth Rate | -15.4 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.54 | |||||
9-Day RSI | 45.26 | |||||
14-Day RSI | 44.71 | |||||
3-1 Month Momentum % | -18.33 | |||||
6-1 Month Momentum % | -33.52 | |||||
12-1 Month Momentum % | 13.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.36 | |||||
Quick Ratio | 1.22 | |||||
Cash Ratio | 0.91 | |||||
Days Inventory | 58.82 | |||||
Days Sales Outstanding | 89.91 | |||||
Days Payable | 60.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19.4 | |||||
Shareholder Yield % | -21.24 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 18.68 | |||||
Operating Margin % | -39.42 | |||||
Net Margin % | -51.18 | |||||
EBITDA Margin % | -24.52 | |||||
FCF Margin % | -40.97 | |||||
OCF Margin % | -38.54 | |||||
ROE % | -31.85 | |||||
ROA % | -17.2 | |||||
ROIC % | -16.25 | |||||
3-Year ROIIC % | -102.49 | |||||
ROC (Joel Greenblatt) % | -41.04 | |||||
ROCE % | -21.85 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4.41 | |||||
PB Ratio | 3.07 | |||||
Price-to-Tangible-Book | 5.34 | |||||
EV-to-EBIT | -10.89 | |||||
EV-to-EBITDA | -21.11 | |||||
EV-to-Revenue | 5.18 | |||||
EV-to-FCF | -12.42 | |||||
Price-to-GF-Value | 1.55 | |||||
Price-to-Median-PS-Value | 1.32 | |||||
Earnings Yield (Greenblatt) % | -9.19 | |||||
FCF Yield % | -8.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kuangli Bio-Tech Holdings Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 377.032 | ||
| EPS (TTM) (NT$) | -2.07 | ||
| Beta | -0.1341 | ||
| 3-Year Sharpe Ratio | 0.04 | ||
| 3-Year Sortino Ratio | 0.07 | ||
| Volatility % | 50.14 | ||
| 14-Day RSI | 44.71 | ||
| 14-Day ATR (NT$) | 0.927788 | ||
| 20-Day SMA (NT$) | 18.58 | ||
| 12-1 Month Momentum % | 13.88 | ||
| 52-Week Range (NT$) | 14.85 - 32 | ||
| Shares Outstanding (Mil) | 97.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kuangli Bio-Tech Holdings Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kuangli Bio-Tech Holdings Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kuangli Bio-Tech Holdings Co Ltd Frequently Asked Questions
What is Kuangli Bio-Tech Holdings Co Ltd(TPE:6431)'s stock price today?
The current price of TPE:6431 is NT$18.20. The 52 week high of TPE:6431 is NT$32.00 and 52 week low is NT$14.85.
When is next earnings date of Kuangli Bio-Tech Holdings Co Ltd(TPE:6431)?
The next earnings date of Kuangli Bio-Tech Holdings Co Ltd(TPE:6431) is .
Does Kuangli Bio-Tech Holdings Co Ltd(TPE:6431) pay dividends? If so, how much?
Kuangli Bio-Tech Holdings Co Ltd(TPE:6431) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Kuangli Bio-Tech Holdings Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers